Diabetes

C-Peptide Levels and Insulin Independence Following Autologous Non-myeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus

Journal of the American Medical Association

Context: In 2007, the effects of the autologous non-myeloablative hematopoietic stem cell transplantation (HSCT) in 15 patients with type 1 diabetes mellitus (DM) were reported. Most patients became insulin free with normal levels of glycated haemoglobin A1c (HbA1c) during a mean 18.8-month follow-up...